Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Novartis AG Sponsored ADR
Telephone
41.61.324.11.11
Address
Lichtstrasse 35, Basel, Basel-Stadt (Basle Town) 4056
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 110.52 - 170.29
Trade Value (12mth)
US$1,341,877.00
1 week
1.49%
1 month
1.15%
YTD
8.86%
1 year
32.42%
All time high
170.29
EPS 3 yr Growth
126.90%
EBITDA Margin
40.90%
Operating Cashflow
$19,242m
Free Cash Flow Return
27.00%
ROIC
19.70%
Interest Coverage
18.90
Quick Ratio
0.90
Shares Outstanding (Fully Diluted)
1,916m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
11-Mar-26
Next Dividend Pay Date
16-Mar-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | 7.18 | 5.91 | 7.25 | | | | ||
EPS (Fully Diluted) | GBP | | | | | 7.12 | 5.86 | 7.19 | | | | ||
Growth | % | | | | | 124.6 | -17.6 | 22.6 | | | | ||
PE | X | | | | | 14.1 | 16.5 | 19 | | | | ||
EV/EBITDA | X | | | | | 11 | 10 | 13.1 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
